Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most... Read more
Singapore: GlaxoSmithKline (GSK) has fired the head of its Chinese R&D unit, Dr Jingwu Zhang, after it was found in a probe that he had fabricated data in a 2010... Read more
Singapore: Mindray Medical has plans to acquire Zonare Medical Systems, an ultrasound technology leader in the high-end radiology segment for $105 million. Mindray's... Read more
The annual list of Asia's fastest growing pharma companies, compiled painstakingly by the BioSpectrum Asia team, is out. A remarkable aspect of the growth of companies... Read more
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a hurdle for Asia to emerge as a center of... Read more
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Theoretically, the synergy created between... Read more
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, any period of extensive growth is often accompanied... Read more
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
